Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-17

Clinical Trial Update: Clinical and Urodynamic Predictors for Sacral Neuromodulation Outcomes in Overactive Bladder

View source ↗

Summary

An update on a study evaluating clinical and urodynamic predictors of sacral neuromodulation outcomes for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacral neuromodulation device (sacral neuromodulation)

Snippet

Sponsor: Assiut University | Conditions: Overactive Bladder | Status: UNKNOWN